Literature DB >> 993951

Experience with 55 Silon pouches.

S Z Rubin, S H Ein.   

Abstract

The application of a Silon pouch usually indicates a desperate if not impossible situation in which the abdominal contents cannot be returned to the abdominal cavity and therefore require some type of covering. Since 1968, we have had experience with 55 Silon pouches in infants and children. Almost all of these pouches were applied to newborns. There were 22 deaths in this series (40%), although 12 of these deaths were in the diaphragmatic hernia group and were almost all due to respiratory failure unrelated to the pouch itself. There were nine deaths in the gastroschisis and omphalocele group (28%) and in all these instances infection (especially Candida) was the underlying cause. While much debate exists as to how the Silon pouch should be handled after its application our series demonstrated that the longer it stayed in place the greater the chance of infection. Furthermore if broad spectrum antibiotics were used for a prolonged period of time, Candida overgrowth of the pouch followed by Candida sepsis and death were almost inevitable.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993951     DOI: 10.1016/0022-3468(76)90106-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Advances in the management of gastroschisis.

Authors:  E E Hrabovsky; J B Boyd; R A Savrin; E T Boles
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

2.  Gastroschisis and omphalocele. An eight-year review.

Authors:  T Mayer; R Black; M E Matlak; D G Johnson
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

3.  Selective repair of neonatal gastroschisis based on degree of visceroabdominal disproportion.

Authors:  E W Fonkalsrud
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

4.  Evolution of staged versus primary closure of gastroschisis.

Authors:  Joseph N Kidd; Richard J Jackson; Samuel D Smith; Charles W Wagner
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.